Astragaloside IV, a glycoside of cyclobutane-type triterpene obtained from Astragalus membranaceus, has the effect of preventing diabetes by inducing a decrease in blood glucose concentration and an increase in plasma insulin levels (Yu et al., 2006). The gene discussed is INS; the disease is diabetes mellitus.